Key result
This review outlines the principles of cardiovascular pharmacogenomics, highlighting lessons from clopidogrel and warfarin and the current status of implementing pharmacogenetic testing in practice.
This review provides a comprehensive overview of cardiovascular pharmacogenomics, highlighting its application in clinical practice and drug development.
No takes yet. Share an insight, caveat, or question.
May inform selective pharmacogenomic testing in CV practice; leaves open prospective trials for standardized implementation.
Roden et al. (2018) conducted a review in Cardiovascular disease. Pharmacogenomics was evaluated. This review outlines the principles of cardiovascular pharmacogenomics, highlighting lessons from clopidogrel and warfarin and the current status of implementing pharmacogenetic testing in practice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: